Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe record history page’s footer/site revision label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site version change rather than a change to the clinical trial record.SummaryDifference0.1%

- Check23 days agoChange DetectedA new record revision v3.5.2 was added and revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision metadata updated from v3.4.3 to v3.5.0 on the Record History page, indicating a new version of the study record.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision history updated: a new entry v3.4.3 was added and the entry for v3.4.2 was removed.SummaryDifference0.1%

- Check88 days agoChange DetectedRecord history shows a new revision v3.4.2 added and an older revision v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision history shows a new entry, v3.4.1, and removal of v3.4.0, indicating a minor update to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.